Maus MV - Search Results

1

A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq.

Boroughs AC, Larson RC, Marjanovic ND, Gosik K, Castano AP, Porter CBM, Lorrey SJ, Ashenberg O, Jerby L, Hofree M, Smith-Rosario G, Morris R, Gould J, Riley LS, Berger TR, Riesenfeld SJ, Rozenblatt-Rosen O, Choi BD, Regev A, Maus MV. Boroughs AC, et al. Among authors: maus mv. Mol Ther. 2020 Dec 2;28(12):2577-2592. doi: 10.1016/j.ymthe.2020.07.023. Epub 2020 Jul 25. Mol Ther. 2020. PMID: 32755564 Free PMC article.

2

The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy.

Bedoya F, Frigault MJ, Maus MV. Bedoya F, et al. Among authors: maus mv. Mol Ther. 2017 Feb 1;25(2):314-320. doi: 10.1016/j.ymthe.2016.11.011. Mol Ther. 2017. PMID: 28153085 Free PMC article. Review.

3

Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment.

Scarfò I, Maus MV. Scarfò I, et al. Among authors: maus mv. J Immunother Cancer. 2017 Mar 21;5:28. doi: 10.1186/s40425-017-0230-9. eCollection 2017. J Immunother Cancer. 2017. PMID: 28331617 Free PMC article. Review.

4

The Why, what, and How of the New FACT standards for immune effector cells.

Maus MV, Nikiforow S. Maus MV, et al. J Immunother Cancer. 2017 Apr 18;5:36. doi: 10.1186/s40425-017-0239-0. eCollection 2017. J Immunother Cancer. 2017. PMID: 28428885 Free PMC article.

5

Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma.

Choi BD, O'Rourke DM, Maus MV. Choi BD, et al. Among authors: maus mv. J Target Ther Cancer. 2017 Aug;6(4):22-25. J Target Ther Cancer. 2017. PMID: 29167820 Free PMC article.

6

Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication.

Kloss CC, Lee J, Zhang A, Chen F, Melenhorst JJ, Lacey SF, Maus MV, Fraietta JA, Zhao Y, June CH. Kloss CC, et al. Among authors: maus mv. Mol Ther. 2018 Jul 5;26(7):1855-1866. doi: 10.1016/j.ymthe.2018.05.003. Epub 2018 May 8. Mol Ther. 2018. PMID: 29807781 Free PMC article. Clinical Trial.

7

Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons.

Choi BD, Curry WT, Carter BS, Maus MV. Choi BD, et al. Among authors: maus mv. Neurosurg Focus. 2018 Jun;44(6):E13. doi: 10.3171/2018.2.FOCUS17788. Neurosurg Focus. 2018. PMID: 29852773 Review.

8

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery.

Tang L, Zheng Y, Melo MB, Mabardi L, Castaño AP, Xie YQ, Li N, Kudchodkar SB, Wong HC, Jeng EK, Maus MV, Irvine DJ. Tang L, et al. Among authors: maus mv. Nat Biotechnol. 2018 Sep;36(8):707-716. doi: 10.1038/nbt.4181. Epub 2018 Jul 9. Nat Biotechnol. 2018. PMID: 29985479 Free PMC article.

9

Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

Scarfò I, Ormhøj M, Frigault MJ, Castano AP, Lorrey S, Bouffard AA, van Scoyk A, Rodig SJ, Shay AJ, Aster JC, Preffer FI, Weinstock DM, Maus MV. Scarfò I, et al. Among authors: maus mv. Blood. 2018 Oct 4;132(14):1495-1506. doi: 10.1182/blood-2018-04-842708. Epub 2018 Aug 8. Blood. 2018. PMID: 30089630 Free PMC article.

10

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.

Choi BD, Maus MV, June CH, Sampson JH. Choi BD, et al. Among authors: maus mv. Clin Cancer Res. 2019 Apr 1;25(7):2042-2048. doi: 10.1158/1078-0432.CCR-18-1625. Epub 2018 Nov 16. Clin Cancer Res. 2019. PMID: 30446589 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters